首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 製藥企業 > 消化器官疾病治療藥的合夥交易•合作動向
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

消化器官疾病治療藥的合夥交易•合作動向

Partneringdesk Deals and alliances in gastrointestinal diseases

出版商 Pharmalicensing Ltd.
出版日期 2006年04月 商品編碼 38283
內容資訊 英文 282 pages
價格
US $ 2495 PDF by E-mail (Single User License)


消化器官疾病治療藥的合夥交易•合作動向 是由出版商Pharmalicensing Ltd.在2006年04月所出版的。 這份英文市場調查報告書包含282 pages 價格從美金2495起跳。

簡介

在全球保健領域之產品策略與事業拓展諮詢上,經驗豐富的英國市調公司 Pharmalicensing (總公司:約克州),詳盡地調查與分析消化器官疾病治療藥的合夥交易•合作動向,並出版綜合報告書 "Partneringdesk Deals and alliances in gastrointestinal diseases"

此報告書在下面的內容裡,不僅說明2001年1月至2006年3月消化器官疾病治療藥240件合夥交易及合作動向,也探討現今活動中的合夥動向、競爭分析及基準、主要25家企業的檔案等。

說明

第1章 各企業的交易概要

第2章 各開發階段的交易概要

第3章 交易種類

  • 各交易業務資料

第4章 產業領域

  • 各產業領域的交易概要
  • 9種產業領域的選擇

第5章 主要25家企業的檔案

  • 過去5年內治療領域的主要企業檔案
  • 企業概要
  • 產業策略
  • 合夥策略
  • 研究開發
  • 歷史
    • aaiPharma
    • Abbott Laboratories
    • AstraZeneca
    • Axcan Pharma Inc
    • BioGaia
    • Biomerica
    • Bradley Pharmaceuticals Inc
    • Celltech
    • 中外製藥股份有限公司
    • DanioLabs Ltd
    • Dr Falk Pharma
    • Dynogen Pharmaceuticals Inc
    • Eli Lilly and Company
    • Food and Drug Administration (FDA)
    • Genzyme Corporation
    • Given Imaging
    • GlaxoSmithKline
    • InKine Pharmaceutical Company
    • Novartis AG
    • Paradigm Genetics
    • Pharmagene
    • Questcor Pharmaceuticals Inc
    • Salix Pharmaceuticals Inc
    • 田邊製藥股份有限公司
    • Viatronix

第6章 交易、合作的詳細情報

  • 2001年1月至2006年3月的交易概要
  • 財務情報

用語

  • 圖1:2001年至2005年的交易
  • 圖2:2005年的交易
  • 圖3:每年的消化器官疾病治療藥交易
  • 圖4:各開發階段(初期)消化器官疾病治療藥的交易
  • 圖5:各開發階段(中期)消化器官疾病治療藥的交易
  • 圖6:各開發階段(後期)消化器官疾病治療藥的交易
  • 圖7:各類消化器官疾病治療藥的交易
  • 圖8:各產業領域的消化器官疾病治療藥交易

目錄

Abstract

Partneringdesk Deals and alliances in gastrointestinal diseases

Partneringdesk deals and alliances in gastrointestinal diseases provides an in-depth view of over 240 deals and alliances announced in gastrointestinal diseases between 2001 and 2006, in a clear and accessible PDF format.

Introduction

A diagrammatical and analytical summary of the deals and dealmakers in the therapy area over a five-year period.

Chapter 1: Deals by company

A comprehensive overview listing deals by company, with a full index of all the deals announced. A clear and easy way to see the activities of any company.

Chapter 2: Deals by development stage

A review of deals by stage of development. Appreciate how deal values change from discovery to launch in the therapy area.

Chapter 3: Deal type

Access deal information by type of transaction - see who is licensing or partnering and using what type of deal.

Chapter 4: Industry sector

Deal announcements sorted by industry sector. Choose from nine sectors.

Chapter 5: Top 25 company profiles

Summary profiles for the most active companies in the therapy area over the past five years, including contact details, business strategy, partnering strategy, R&D and history.

Chapter 6: Detailed listing of deals and alliances

A full index of all the deals announced between Jan 2001 and Mar 2006. Every deal entry includes a detailed deal description and financial information where disclosed, such as headline values, upfront and milestone payments.

Every deal entry includes a detailed deal description and financial information where disclosed, such as headline values, upfront and milestone payments, and links to the full deal in the deal listing at the rear of each report.

Table of Contents

Introduction

About Partneringdesk deals and alliances

Chapter 1: Deals in gastrointestinal diseases by company

Chapter 2: Deals in gastrointestinal diseases by development stage

Chapter 3: Deals in gastrointestinal diseases by type

Chapter 4: Deals in gastrointestinal diseases by industry sector

Chapter 5: Summary profiles for the most active companies in gastrointestinal diseases

Chapter 6: List of deals

Glossary

Back to Top